Search
for
Sort by
Research 271–300 of 1000+
- Preliminary Toxicity Profile of Arotinoids SMR-2 and SMR-6 in Male B6D2F1 Mice
- Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma
- 607 Cutaneous overexpression of cyclooxygenase-2 models androgenetic alopecia in adult mice
- SARS‐CoV‐2 & androgenic alopecia: exploring links!
- Paper 2. Epigallocatechin Gallate and Tannic Acid Based Formulations of Finasteride for Dermal Administration and Chemoembolization
- FC 2-2 : Therapeutic Effects of Growth Factor Cocktail (CellcurinTM) containing FGF5s (fibroblast growth factor 5 short) and NMN (nicotinamide mononucleotide) applied on the scalp in the patients with androgenetic alopecia: a split study
- Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis
- Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Vitiligo - Part 2 - classification, histopathology and treatment
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- The biochemical and phenotypic characterization of females homozygous for 5 alpha-reductase-2 deficiency.
- 5 alpha-reductase-2 gene mutations in the Dominican Republic.
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Involvement of 4‐hydroxy‐2‐nonenal in pollution‐induced skin damage
- Epidermal Dysplasia and Abnormal Hair Follicles in Transgenic Mice Overexpressing Homeobox Gene MSX-2
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- 1α,25(OH)2-Dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway